Epica International, Inc.

Epica International develops medical imaging and precision robotics platforms for human healthcare, veterinary medicine and industrial manufacturing. Its business combines computed tomography technology, imaging software and automated manufacturing systems through specialized operating subsidiaries in the United States and Italy.

The company's imaging portfolio centers on High-Definition Volumetric Imaging (HDVI). Its systems support diagnostic and procedural imaging across clinical hospitals, veterinary practices and equine facilities. The portfolio includes SeeFactor CT3, a mobile platform combining computed tomography, fluoroscopy and digital radiography; Vimago, a veterinary CT platform; and Pegaso, an equine imaging system designed for examinations of standing or recumbent horses. SeeFactor CT3 has received FDA 510(k) clearance.

Imaging and automation

Epica's imaging activities encompass system engineering, assembly, calibration, distribution and proprietary software development. Its veterinary and human-health businesses address different clinical requirements, while Italian subsidiary Imaginalis contributes scanner engineering and manufacturing. Peregrine Radiology supports radiologist consultation and image-interpretation workflows within the wider business.

Industrial robotics activities operate primarily through Fabrica Machinale, under the Roboticom brand. These systems address specialized manufacturing tasks, including custom orthotic and prosthetic model carving and automated surface finishing. Ortis provides seven-axis robotic carving, while SandRob supports sanding, grinding, trimming and polishing applications. These activities serve orthotics and prosthetics manufacturers as well as automotive, aerospace, marine and other industrial markets.

Development and operating history

Founded by Greg Stoutenburgh in the 2013–2014 period, Epica developed around the combination of high-resolution imaging and robotics. Its North American operating base shifted from California to South Carolina, where it expanded manufacturing and assembly operations in 2021 and relocated its North American headquarters in late 2023.

The company's operating model brings together specialized healthcare and industrial businesses rather than a single uniform product line. Equipment integration, technical support and maintenance complement its hardware and software activities, connecting product development with installation and continued use in clinical and manufacturing environments.